ID

34573

Descrizione

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238

collegamento

https://clinicaltrials.gov/show/NCT02240238

Keywords

  1. 19/01/19 19/01/19 -
  2. 28/09/20 28/09/20 -
  3. 01/10/20 01/10/20 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

19 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Solid Tumors NCT02240238

Eligibility Solid Tumors NCT02240238

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
(part 1 only) have a histologically or cytologically confirmed diagnosis of advanced solid tumor that has relapsed or is refractory to standard curative or palliative therapy or has a contraindication to standard therapy.
Descrizione

ID.1

Tipo di dati

boolean

(part 2 only) have histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc and have received 1 or 2 lines of prior chemotherapy or targeted therapy for stage iiib or iv nsclc (second- or third-line).
Descrizione

ID.2

Tipo di dati

boolean

have measurable disease per response evaluation criteria in solid tumors (recist) version 1.1.
Descrizione

ID.3

Tipo di dati

boolean

eastern cooperative oncology group (ecog) performance status of 0 to 1
Descrizione

ID.4

Tipo di dati

boolean

have adequate bone marrow reserve, liver function, and renal function
Descrizione

ID.5

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
have received prior platinum therapy in the past 3 months
Descrizione

ID.6

Tipo di dati

boolean

have received prior cisplatin and gemcitabine concomitantly within the last 6 months or are refractory to cisplatin and gemcitabine.
Descrizione

ID.7

Tipo di dati

boolean

unresolved toxicity from prior radiation, chemotherapy, or other targeted treatment, including investigational treatment
Descrizione

ID.8

Tipo di dati

boolean

pregnant or breast feeding
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Solid Tumors NCT02240238

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
(part 1 only) have a histologically or cytologically confirmed diagnosis of advanced solid tumor that has relapsed or is refractory to standard curative or palliative therapy or has a contraindication to standard therapy.
boolean
ID.2
Item
(part 2 only) have histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc and have received 1 or 2 lines of prior chemotherapy or targeted therapy for stage iiib or iv nsclc (second- or third-line).
boolean
ID.3
Item
have measurable disease per response evaluation criteria in solid tumors (recist) version 1.1.
boolean
ID.4
Item
eastern cooperative oncology group (ecog) performance status of 0 to 1
boolean
ID.5
Item
have adequate bone marrow reserve, liver function, and renal function
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
have received prior platinum therapy in the past 3 months
boolean
ID.7
Item
have received prior cisplatin and gemcitabine concomitantly within the last 6 months or are refractory to cisplatin and gemcitabine.
boolean
ID.8
Item
unresolved toxicity from prior radiation, chemotherapy, or other targeted treatment, including investigational treatment
boolean
ID.9
Item
pregnant or breast feeding
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial